Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclyl substituted pyrrolopyridines that are inhibitors of the CDK12 kinase

Heterocyclyl substituted pyrrolopyridines that are inhibitors of the CDK12 kinase

US Patent 11407767 · Granted Aug 9, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2,6,9-trisubstituted purines2025
Fused tricyclic compounds useful as anticancer agents2025
Chemical compounds as antibiotics2021
Pyrimidine derivatives and their use in the treatment of cancer and further dise2017
(trimethoxyphenylamino) pyrimidinyl formulations2015
Pyrimidline derivatives having immune modulating properties that act via TLR7 fo2014
Salts 7562013
Quinuclidine derivatives as muscarinic M3 receptor antagonists2012
Compounds2012
Salt2010